Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totaling 342,847 shares, an increase of 286.3% from the September 30th total of 88,752 shares. Currently, 14.9% of the company’s stock are short sold. Based on an average trading volume of 5,307,777 shares, the days-to-cover ratio is presently 0.1 days.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Arcadia Biosciences in a report on Tuesday, September 22nd. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company currently has an average rating of “Sell”.
View Our Latest Stock Analysis on Arcadia Biosciences
Arcadia Biosciences Stock Performance
NASDAQ:RKDA traded up $0.00 during mid-day trading on Thursday, reaching $0.16. The stock had a trading volume of 581,134 shares, compared to its average volume of 1,519,228. The business has a 50 day simple moving average of $0.35 and a 200 day simple moving average of $1.05. Arcadia Biosciences has a twelve month low of $0.11 and a twelve month high of $4.18. The firm has a market capitalization of $389,938.00, a price-to-earnings ratio of -0.04 and a beta of 0.56.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The company had revenue of $1.44 million during the quarter, compared to analyst estimates of $1.90 million.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications.
Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients.
Further Reading
- Five stocks we like better than Arcadia Biosciences
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
